Revealing the
Therapeutic
Power of
mTORC1

Our oral mTORC1 activator, NV-5138, advanced into human clinical studies for Treatment-Resistant Depression in June 2018.
© 2018 Navitor Pharmaceuticals, Inc.. All rights reserved.
HOME | SITEMAP | CONTACT
Back to Top